Oscar Health, Inc. (OSCR) Stock Price: $28.40+0.13 (+0.46%)
At close: Jun 18, 2026, 4:00 PM ET
The closing share price for Oscar Health, Inc. (OSCR) stock was $28.40 for Thursday, June 18, 2026, up 0.46% on the day.
Longer view (total return, dividends reinvested): past 12 months +51.4% · 3-year avg +47.4%/yr · 5-year avg +3.5%/yr
OSCR Price Chart
OSCR is featured in
OSCR Key Metrics
See All MetricsLAST CLOSE PRICE
$28.40
52-WEEK RANGE
$10.69 - $29.81
BETA
2.39
% FROM 52W HIGH
-4.73%
MARKET CAP
$7.36B
DIVIDEND YIELD
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
next-FY estimate
21.28
P/B RATIO
5.63
DEBT / EQUITY
0.44
REVENUE TTM
$13.30B
NET INCOME TTM
-$39.43M
NET PROFIT MARGIN TTM
-0.30%
TTM TOTAL RETURN
+51.35%
3Y TOTAL RETURN
+47.38%
5Y TOTAL RETURN
+3.55%
OSCR Earnings Preview
Next Earnings Date
Aug 5, 2026
45 days away
EPS Estimate
0.34
Revenue Est.
$4.73B
Last Quarter Results
EPS
$2.07
vs Estimate
$1.10
Revenue
$4.58B
vs Estimate
$4.89B
OSCR Analyst Ratings
Consensus Rating
Based on 10 analysts
Average Price Target
$22.60
-20.4% downside
Low
$13.00
Current
$28.40
High
$35.00
OSCR Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $1.89 | $2.10 | $2.23 | 2 |
| Q2 2027 | $0.48 | $0.54 | $0.57 | 2 |
| Q3 2027 | $-0.08 | $-0.07 | $-0.07 | 2 |
| Q4 2027 | $-1.26 | $-1.18 | $-1.06 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $0.05 | $1.33 | $2.43 | 6 |
| FY 2028 | $1.90 | $2.11 | $2.33 | 4 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $4.72B | $5.12B | $5.37B | 2 |
| Q2 2027 | $4.76B | $5.17B | $5.42B | 2 |
| Q3 2027 | $4.67B | $5.07B | $5.31B | 2 |
| Q4 2027 | $4.49B | $4.87B | $5.11B | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $19.63B | $19.89B | $20.16B | 7 |
| FY 2028 | $22.12B | $22.19B | $22.25B | 6 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
HealthcareOSCR Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1OSCR | $7.36B | $28.40 | +0.46% | +51.35% | +3.55% | N/A | — |
| 2BIO | $7.64B | $282.44 | -0.78% | +21.76% | -14.63% | +7.20% | vs OSCR |
| 3HIMS | $7.91B | $35.47 | +11.23% | -41.94% | +26.16% | N/A | vs OSCR |
| 4TEM | $8.87B | $50.84 | +4.20% | -26.44% | N/A | N/A | vs OSCR |
| 5CRL | $8.91B | $185.00 | +1.46% | +27.35% | -12.16% | +8.46% | vs OSCR |
| 6BAX | $10.27B | $19.89 | +2.58% | -32.71% | -22.91% | -6.27% | vs OSCR |
OSCR Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Oscar Health, Inc.
Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Mark Thomas Bertolini